Insomnia is the most common sleep disorder and is believed to affect approximately 35% of the global population. The condition can be defined as patient-reported difficultly with sleep initiation or sleep maintenance which can include frequent awakenings, difficulty returning to sleep after awakenings, or awakening too early with inability to return to sleep. Cases of insomnia can be classified on the basis of etiology into primary and secondary (or comorbid) subtypes.
This report elaborates the market size, market characteristics, and market growth of the Insomnia Therapeutics industry, and breaks down according to the type, application, and consumption area of Insomnia Therapeutics. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Insomnia Therapeutics in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Insomnia Therapeutics market covered in Chapter 13:
Juste
Dainippon Sumitomo
Merck & Co.
Pfizer
Meda
Sunovion
Pernix Therapeutics
Astellas
ECR Pharmaceuticals
Fidia Farmaceutici
Neurim
Eisai
Medice Arzneimittel
Takeda
Flynn Pharma
Sanofi
Purdue

In Chapter 6, on the basis of types, the Insomnia Therapeutics market from 2015 to 2025 is primarily split into:
Drugs
Medical Devices

In Chapter 7, on the basis of applications, the Insomnia Therapeutics market from 2015 to 2025 covers:
Prescription
Over-the-Counter (OTC)

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025